Market Cap 444.15M
Revenue (ttm) 10.01M
Net Income (ttm) -337.71M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -3,373.73%
Debt to Equity Ratio 0.00
Volume 2,732,000
Avg Vol 2,116,766
Day's Range N/A - N/A
Shares Out 169.52M
Stochastic %K 10%
Beta 1.65
Analysts Strong Sell
Price Target $19.64

Latest News on RLAY

Relay Therapeutics: A Precision Oncology Play Worth The Risk

Feb 14, 2025, 2:17 AM EST - 6 weeks ago

Relay Therapeutics: A Precision Oncology Play Worth The Risk


Crude Oil Gains Over 1%; Relay Therapeutics Shares Spike Higher

Sep 9, 2024, 2:16 PM EDT - 7 months ago

Crude Oil Gains Over 1%; Relay Therapeutics Shares Spike Higher


Relay Therapeutics to Participate in Upcoming Investor Conferences

May 21, 2024, 4:05 PM EDT - 11 months ago

Relay Therapeutics to Participate in Upcoming Investor Conferences